Baxter(US:BAX) Globenewswire·2025-10-30 13:07Core Viewpoint - Baxter International Inc. is facing a securities fraud class action lawsuit due to alleged misrepresentations regarding the safety of its Novum IQ Large Volume Pump, which is claimed to have systemic issues that could endanger patients [3][4]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the Northern District of Illinois on behalf of investors who purchased Baxter common stock between February 23, 2022, and July 30, 2025 [3]. - The allegations include violations of the Securities Exchange Act of 1934 against Baxter and certain senior officers [3]. Group 2: Investor Participation - Investors who wish to serve as lead plaintiffs must file papers by December 15, 2025, and can act on behalf of other class members [5]. - Participation as a lead plaintiff is not required to share in any potential recovery, and all representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [5]. Group 3: Law Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [6]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [6].